Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Effects of lapatinib and trastuzumab on progression free survival

Dr Nancy Lin – Dana Farber Cancer Institute, Boston, MA, USA
Effects of lapatinib and trastuzumab on progression free survival ( Dr Nancy Lin – Dana Farber Cancer Institute, Boston, MA, USA )
15 Jun 2012

Intermittent hormonal therapy versus continuous therapy for advanced prostate cancer

Dr Maha Hussain - University of Michigan, Ann Arbor, USA
Intermittent hormonal therapy versus continuous therapy for advanced prostate cancer ( Dr Maha Hussain - University of Michigan, Ann Arbor, USA )
3 Jun 2012

Intermittent hormonal therapy less effective than continuous therapy when treating advanced prostate cancer

Dr Maha Hussain - University of Michigan, Ann Arbor, USA
Intermittent hormonal therapy less effective than continuous therapy when treating advanced prostate cancer ( Dr Maha Hussain - University of Michigan, Ann Arbor, USA )
3 Jun 2012

Highlights and goals of IMPAKT 2012

Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium
Highlights and goals of IMPAKT 2012 ( Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium )
17 May 2012

Endocrine therapy and endocrine resistant breast cancer

Prof Mitch Dowsett – The Institute for Cancer Research, London, UK
Endocrine therapy and endocrine resistant breast cancer ( Prof Mitch Dowsett – The Institute for Cancer Research, London, UK )
17 May 2012

Targeting DNA damage response and repair excluding PARP for triple negative breast cancer

Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden
Targeting DNA damage response and repair excluding PARP for triple negative breast cancer ( Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden )
17 May 2012

Molecular characterisation of breast cancer: the mutational landscape

Prof Sam Aparicio - University of British Columbia, Vancouver, Canada
Molecular characterisation of breast cancer: the mutational landscape ( Prof Sam Aparicio - University of British Columbia, Vancouver, Canada )
17 May 2012

New cyclin-dependent kinase inhibitor with letrozole for ER+/HER2- breast cancer

Prof Richard Finn - Universtity of California, Los Angeles, USA
New cyclin-dependent kinase inhibitor with letrozole for ER+/HER2- breast cancer ( Prof Richard Finn - Universtity of California, Los Angeles, USA )
17 May 2012

Criteria required before implementation of whole genome arrays in clinical practice

Prof Daniel Hays - University of Michigan, Ann Arbor, USA
Criteria required before implementation of whole genome arrays in clinical practice ( Prof Daniel Hays - University of Michigan, Ann Arbor, USA )
17 May 2012

Prognostic significance of progesterone receptor-positive tumour cells within luminal A breast cancer

Dr Aleix Prat - University of North Carolina, USA
Prognostic significance of progesterone receptor-positive tumour cells within luminal A breast cancer ( Dr Aleix Prat - University of North Carolina, USA )
17 May 2012

Pregnancy following oestrogen receptor-positive breast cancer is safe

Dr Hatem A. Azim - Institut Jules Bordet, Brussels, Belgium
Pregnancy following oestrogen receptor-positive breast cancer is safe ( Dr Hatem A. Azim - Institut Jules Bordet, Brussels, Belgium )
12 Apr 2012

A pregnancy pill to prevent breast cancer?

Prof Valerie Beral - University of Oxford
A pregnancy pill to prevent breast cancer? ( Prof Valerie Beral - University of Oxford )
4 Apr 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation